1.
Therapie
; 70(6): 545-6, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26242497
RESUMO
Mitotane provided serious side effects and low doses seemed to be tolerated. Determination of mitotane concentration in plasma is recommended. We report the case of toxic plasma levels with low doses of mitotane in a 47-year-old man with adrenocortical cancer.